In 1969, David Cohen and James Zimmerman were the first to measure the magnetic field from a human heart using the technology.
New MR Analysis Technique Reveals Patients' Response to Anti-angiogenesis Therapy
A Nature Medicine study by the Martinos Center's Kyrre Emblem and colleagues has garnered quite a bit of attention lately. Features about the work have appeared in NIH Research Matters, Nature Med podcasts (September issue), Aunt Minnie, AACR Cancer Discovery highlights, Voices Against Brain Cancer, The ASCO post and more.
In the study, titled "Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy," the researchers report a new means of analyzing MR imaging data that can reveal whether brain tumors are responding to anti-angiogenesis therapy. This would of course prove helpful in determining the most appropriate treatments, or in deciding to discontinue treatments that are not effective.
Read the MGH press release about the study here.